The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine as a novel, nonpeptide substance P antagonist
作者:John A. Lowe、Susan E. Drozda、R. Michael Snider、Kelly P. Longo、Stevin H. Zorn、Jean Morrone、Elisa R. Jackson、Stafford McLean、Dianne K. Bryce
DOI:10.1021/jm00092a009
日期:1992.7
describe the structure-activity relationship development of a series of quinuclidines which culminated in the first potent, selective, nonpeptide substance P (SP) antagonist, (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxy-phenyl)methyl]-1- azabicyclo[2.2.2]octan-3-amine, 3 (CP-96,345). Compound 3 is a potent displacer of [3H]SP binding in human IM-9 cells and blocks SP-induced and capsaicin-induced plasma
我们描述了一系列喹啉核苷的结构-活性关系发展,该喹啉核苷在第一个有效的,选择性的,非肽类物质P(SP)拮抗剂,(2S,3S)-顺-2-(二苯基甲基)-N-[(2-甲氧基-苯基)甲基] -1-氮杂双环[2.2.2]辛-3-胺,(CP-96,345)3。化合物3是人IM-9细胞中[3H] SP结合的有效置换剂,并在体内阻断了SP诱导的和辣椒素诱导的血浆外渗以及SP诱导的唾液分泌。这种化合物既可以帮助我们进一步了解小分子与肽受体的相互作用,又可以评估SP拮抗剂的治疗潜力。